Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127211471 | 12721147 | 1 | I | 20160831 | 20160907 | 20160907 | EXP | PHHY2016BR121651 | NOVARTIS | 0.00 | M | Y | 63.00000 | KG | 20160907 | CN | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127211471 | 12721147 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 MG, QD PATCH 10 (CM2) | Y | U | 651210 | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | |||
| 127211471 | 12721147 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 13.3 MG, PATCH 15 (CM2) | Y | U | 686330 | 22083 | 13.3 | MG | TRANS-THERAPEUTIC-SYSTEM | ||||
| 127211471 | 12721147 | 3 | C | GARDENAL//PHENOBARBITAL | PHENOBARBITAL | 1 | Oral | 100 MG, QD | 542570 | 0 | 100 | MG | TABLET | QD | |||||
| 127211471 | 12721147 | 4 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | U | 0 | TABLET | |||||||||
| 127211471 | 12721147 | 5 | C | SOMALGIN | ASPIRINDIHYDROXYALUMINUM AMINOACETATE ANHYDROUSMAGNESIUM CARBONATE | 1 | Unknown | 100 MG, QD | U | 818898 | 0 | 100 | MG | QD | |||||
| 127211471 | 12721147 | 6 | C | MEMANTINE. | MEMANTINE | 1 | Oral | 10 MG, BID | 1520129 | 0 | 10 | MG | TABLET | BID | |||||
| 127211471 | 12721147 | 7 | C | MILGAMMA | VITAMIN B | 1 | Oral | 150 MG, QD | 15H096 | 0 | 150 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127211471 | 12721147 | 1 | Memory impairment |
| 127211471 | 12721147 | 3 | Cestode infection |
| 127211471 | 12721147 | 4 | Blood cholesterol increased |
| 127211471 | 12721147 | 5 | Cardiac disorder |
| 127211471 | 12721147 | 6 | Product used for unknown indication |
| 127211471 | 12721147 | 7 | Hypovitaminosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127211471 | 12721147 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127211471 | 12721147 | Agitation | |
| 127211471 | 12721147 | Cholelithiasis | |
| 127211471 | 12721147 | Condition aggravated | |
| 127211471 | 12721147 | Dizziness | |
| 127211471 | 12721147 | Feeling abnormal | |
| 127211471 | 12721147 | Memory impairment | |
| 127211471 | 12721147 | Muscle rigidity | |
| 127211471 | 12721147 | Nervousness | |
| 127211471 | 12721147 | Pain in extremity | |
| 127211471 | 12721147 | Polyneuropathy | |
| 127211471 | 12721147 | Somnolence | |
| 127211471 | 12721147 | Weight decreased | |
| 127211471 | 12721147 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127211471 | 12721147 | 1 | 201601 | 0 |